Methodology for Percutaneous Nephrolithotomy (PCNL) in Emphysematous Pyelonephritis (EP)
Background in abstract: Diabetes mellitus and obstructive uropathy from urinary calculi are frequently linked to emphysematous pyelonephritis (EP), a severe and sometimes fatal renal infection marked by gas production in the renal parenchyma. A major therapeutic problem that necessitates quick and efficient intervention is the management of individuals with EP who also have renal stones. With an emphasis on intraoperative results, complication rates, and postoperative recovery metrics, the purpose of this study is to assess the safety and effectiveness of percutaneous nephrolithotomy (PCNL) in patients with emphysematous pyelonephritis. Methods: Data from patients who had PCNL for renal stones in the setting of emphysematous pyelonephritis within a certain time period were gathered for a retrospective analysis. Patient demographics, stone burden, laboratory results, pre-operative treatment techniques, intraoperative specifics, and postoperative problems were among the important factors assessed. Validated rating systems were used to evaluate quality of life after surgery. Findings: The study included 21 patients in all, with an average age of 55.3 years. Fifteen cases (71.4%) of patients had problems from diabetes mellitus when they first arrived. With Major Complications 2 (9.5%), Minor Complications 3 (14.3%), where the results of quality of life evaluations performed three months after surgery showed notable improvements in kidney function and symptomatic alleviation. In conclusion, our findings are in support of PCNL being a safe and effective treatment for patients with emphysematous pyelonephritis and renal stones
Institutions
- Baghdad Medical City (IQ)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-05-15
- DOI
- https://doi.org/10.5281/zenodo.15427566
- Primary Topic
- Infectious Disease Case Reports and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00